Integral Biosciences Private Limited - Company Profile

It is a pharma private limited company based in New Delhi, Delhi, India, established in 2007.

2007 New Delhi, Delhi, India Active

Last Updated: December 15, 2025

About Integral Biosciences Private Limited

Integral Biosciences Private Limited, a active private limited company, was established on 17 April 2007 in New Delhi, Delhi, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U73100DL2007PTC162147. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹3.68 Cr and a paid-up capital of ₹1.40 Cr.

It upholds a compliant status. Employing 80 professional, Its leadership includes Ram Thakkar (Whole-Time Director), Devyani Kantawala (Whole-Time Director), Sanjeev Kumar Rajora (Additional Director). Past directors included Ram Thakkar, Devyani Kantawala, Sarvajit Chakravarty. It holds ₹4.85 Cr open charges and ₹7.03 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 51-52, 5Th Floor, Gedore House, Nehru Place, New Delhi, Delhi, 110019.

Company Details

CIN/LLPIN
U73100DL2007PTC162147
Registration Number
162147
Incorporation Date
17 April 2007
Authorized Capital
₹3.68 Cr
Paid-Up Capital
₹1.40 Cr
ROC Code
Roc Delhi
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 3.68 Cr as on 15-12-2025
Paid Up Capital ₹ 1.40 Cr as on 15-12-2025
Company Age 18 Year, 10 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 4.85 Cr as on 15-12-2025
Satisfied Charges ₹ 7.03 Cr as on 15-12-2025
Revenue Growth **** 11.65% (FY 2023)
Profit Growth **** 129.56% (FY 2023)
Ebitda **** -82.77% (FY 2023)
Net Worth 35.50% (FY 2023)
Total Assets **** 7.09% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Integral Biosciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Integral Biosciences Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Ram Thakkar	Whole-Time Director	17 Apr 2007	Current
Devyani Kantawala	Whole-Time Director	30 Sep 2014	Current
Sanjeev Kumar Rajora	Additional Director	14 Apr 2025	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	30 Sep 2014	Past
Pramod Abcsdd	Director	30 Sep 2014	Past
Pramod Abcsdd	Additional Director	30 Nov 2018	Past
Pramod Abcsdd	Director	30 Sep 2014	Past
Pramod Abcsdd	Director	13 Oct 2014	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Integral Biosciences.

Integral Biosciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11.65% increase. The company also saw a substantial improvement in profitability, with a 129.56% increase in profit. The company's net worth Soared by an impressive increase of 35.5%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

11.65%

*******

Revenue from Operations

*******

-36.83%

*******

Total Assets

*******

7.09%

*******

Profit or Loss

*******

129.56%

*******

Net Worth

*******

35.50%

*******

EBITDA

*******

-82.77%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Integral Biosciences?

In 2023, Integral Biosciences had a promoter holding of 82.26% and a public holding of 17.75%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹48,500,000.00

Satisfied Charges

₹70,295,000.00

Charges Breakdown by Lending Institutions

Citi Bank N.A. : 3.50 Cr
State Bank Of India : 1.50 Cr
Others : 1.13 Cr
Axis Bank Limited : 0.90 Cr

Latest Charge Details

Date	Lender	Amount	Status
10 Jun 2020	Axis Bank Limited	₹9.00 M	Satisfied
13 Dec 2019	Others	₹7.00 M	Satisfied
22 Feb 2018	Others	₹0.39 M	Satisfied
10 Mar 2017	Others	₹2.85 M	Satisfied
31 Mar 2016	Others	₹0.70 M	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Integral Biosciences?

Integral Biosciences has a workforce of 80 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Integral Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Integral Biosciences's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Integral Biosciences

Recent Activity within the Organization

Charges

Progress on A charge registered on 14 Nov 2007 via Charge ID 10081362 with State Bank Of India was fully satisfied on 29 Aug 2025. was documented.
29 Aug 2025
Charges

A charge with State Bank Of India of Rs. 1.50 Cr registered on 14 Nov 2007 with Charge ID 10081362 was modified on 07 Jul 2025. was recorded as a recent event.
07 Jul 2025
Charges

The activity A charge registered on 13 Dec 2019 via Charge ID 100313697 with Others was fully satisfied on 02 Jul 2025. was completed.
02 Jul 2025
Charges

Progress on A charge registered on 10 Jun 2020 via Charge ID 100347851 with Axis Bank Limited was fully satisfied on 06 Jun 2025. was documented.
06 Jun 2025
Director Appointment

The activity Sanjeev Kumar Rajora was appointed as a Additional Director was appointed as a Additional Director on 14 Apr 2025 & has been associated with this company since 10 months 19 days . was completed.
14 Apr 2025
Annual General Meeting

The activity Integral Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
30 Sep 2024

Explore recent activity and updates - View Recent Activity